Showing results (11-20 of 392) with videos related to
Sort By:
Pageof 40
Translational Lung Cancer Research|March 26, 2015
Targeted therapy in NSCLC driven by HER2 insertionsSolange Peters, Stefan ZimmermannCancer Treatment Reviews|April 8, 2023
Immunotherapy-based combinations in metastatic NSCLCAakash Desai, Solange PetersCurrent Treatment Options in Oncology|May 30, 2018
Management of Resistance to First-Line Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor TherapySolange Peters, Stefan ZimmermannThoracic Surgery Clinics|December 18, 2008
Definitive chemoradiotherapy for non-small cell lung cancer with N2 diseaseShilpen Patel, Rachel E Sanborn, Charles R ThomasThoracic Surgery Clinics|December 18, 2008
Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvementBrandon H Tieu, Rachel E Sanborn, Charles R ThomasNature Reviews. Clinical Oncology|May 9, 2012
MET: a promising anticancer therapeutic targetSolange Peters, Alex A AdjeiNature Reviews. Clinical Oncology|December 3, 2014
Lung cancer. How much platinum-based chemotherapy is enough in NSCLC?Solange Peters, Alex A AdjeiCancer Treatment Reviews|April 25, 2014
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastasesStefan Zimmermann, Rafal Dziadziuszko, Solange PetersJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2023
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?Dipesh Uprety, Jordi Remon, Solange PetersCancer Cell|November 10, 2020
Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for ConvergenceAntonio Passaro, Albrecht Stenzinger, Solange PetersPageof 40